Search research articles
Contact Us
Filters
Showing results (151-160 of 271) with videos related to
Page
of 28
Sort By:
Antimicrobial Agents and Chemotherapy
|
December 1, 1996
Comparative serum bactericidal activities of ceftizoxime and cefotaxime against intermediately penicillin-resistant Streptococcus pneumoniae
K B Patel, D P Nicolau, C H Nightingale, et al.
Antimicrobial Agents and Chemotherapy
|
January 1, 1988
Effect of protein binding on drug penetration into blister fluid
W C Shyu, R Quintiliani, C H Nightingale, et al.
DICP : the Annals of Pharmacotherapy
|
March 1, 1991
Cost considerations of conversion from aminoglycoside-containing combination regimens to ceftriaxone
L L Briceland, W R Outman, C H Nightingale, et al.
The Journal of Infectious Diseases
|
November 1, 1981
Stability of cephalosporins in commercial sera
W C Shyu, C H Nightingale, R Quintiliani, et al.
Laboratory Animal Science
|
April 1, 1994
Caution in the use of commercial serum
P R Tessier, D P Nicolau, C O Onyeji, et al.
The Journal of Antimicrobial Chemotherapy
|
June 1, 1997
Once-daily dosing of aminoglycosides: review and recommendations for clinical practice
C D Freeman, D P Nicolau, P P Belliveau, et al.
The Journal of Antimicrobial Chemotherapy
|
December 1, 1984
Integration of pharmacokinetics and pharmacodynamics of methicillin in curative treatment of experimental endocarditis
F M Gengo, T W Mannion, C H Nightingale, et al.
Laboratory Animal Science
|
February 1, 1995
Disposition kinetics of aspirin in female New Zealand white rabbits
M N Marangos, C O Onyeji, D P Nicolau, et al.
The Annals of Thoracic Surgery
|
February 1, 1981
A comparison of the penetration characteristics of cephapirin and cephalothin into right atrial appendage, muscle, fat, and pericardial fluid of pediatric patients undergoing open-heart operation
E R Green, S Subramanian, H Faden, et al.
Chemotherapy
|
July 8, 1999
Pharmacodynamics of intermittent- and continuous-infusion cefepime alone and in combination with once-daily tobramycin against Pseudomonas aeruginosa in an in vitro infection model
P R Tessier, D P Nicolau, C O Onyeji, et al.
Page
of 28
Search research articles
Search
Showing results (151-160 of 271) with videos related to
Sort By:
Page
of 28
Antimicrobial Agents and Chemotherapy
|
December 1, 1996
Comparative serum bactericidal activities of ceftizoxime and cefotaxime against intermediately penicillin-resistant Streptococcus pneumoniae
K B Patel, D P Nicolau, C H Nightingale, et al.
Antimicrobial Agents and Chemotherapy
|
January 1, 1988
Effect of protein binding on drug penetration into blister fluid
W C Shyu, R Quintiliani, C H Nightingale, et al.
DICP : the Annals of Pharmacotherapy
|
March 1, 1991
Cost considerations of conversion from aminoglycoside-containing combination regimens to ceftriaxone
L L Briceland, W R Outman, C H Nightingale, et al.
The Journal of Infectious Diseases
|
November 1, 1981
Stability of cephalosporins in commercial sera
W C Shyu, C H Nightingale, R Quintiliani, et al.
Laboratory Animal Science
|
April 1, 1994
Caution in the use of commercial serum
P R Tessier, D P Nicolau, C O Onyeji, et al.
The Journal of Antimicrobial Chemotherapy
|
June 1, 1997
Once-daily dosing of aminoglycosides: review and recommendations for clinical practice
C D Freeman, D P Nicolau, P P Belliveau, et al.
The Journal of Antimicrobial Chemotherapy
|
December 1, 1984
Integration of pharmacokinetics and pharmacodynamics of methicillin in curative treatment of experimental endocarditis
F M Gengo, T W Mannion, C H Nightingale, et al.
Laboratory Animal Science
|
February 1, 1995
Disposition kinetics of aspirin in female New Zealand white rabbits
M N Marangos, C O Onyeji, D P Nicolau, et al.
The Annals of Thoracic Surgery
|
February 1, 1981
A comparison of the penetration characteristics of cephapirin and cephalothin into right atrial appendage, muscle, fat, and pericardial fluid of pediatric patients undergoing open-heart operation
E R Green, S Subramanian, H Faden, et al.
Chemotherapy
|
July 8, 1999
Pharmacodynamics of intermittent- and continuous-infusion cefepime alone and in combination with once-daily tobramycin against Pseudomonas aeruginosa in an in vitro infection model
P R Tessier, D P Nicolau, C O Onyeji, et al.
Page
of 28